Skip to main content
. 2020 Dec 15;106(3):e1170–e1178. doi: 10.1210/clinem/dgaa930

Table 2.

Imaging and adrenal vein sampling details according to indication for repeat sampling

Patient Imaging results Reason for repeat AVS AVS 1 result Time interval, mo AVS 2 result Final outcome, management details
1 No lesion Failed R cath bRSI 1.0
sRSI 1.5
4 bRSI 1.8
sRSI 35.7
Success; lateralized R; normal BP on MRA
2 14 mm L Failed R cath bRSI 1.0
sRSI 1.2
3 bRSI 0.9
sRSI 1.0
Failed AVS; L ADx based on CT
3 15 mm L Contralateral LI bLI 6.0 (R) 7 bLI 5.1 (R) Same results
4 16 mm L Contralateral LI bLI 15.3 (R) 2 bLI 4.2 (R) Same resultsa NP-59 scan shows hyperfunctioning L adrenal mass; surgery to remove tumor was curative
5 9 mm R Failed L cath bLSI 1.1
sLSI 2.0
7 bLSI 13.2
sLSI 86.2
Success; lateralized R
6 9 mm L Contralateral LI bLI 6.0 (R)
sLI 3.7 (R)
5 bLI 1.6 (R)
sLI 9.1 (R)
Same results
7 28 mm R Contralateral LI bLI 3.1 (L)
sLI 4.1 (L)
2 bLI 2.6 (L)
sLI 3.7 (L)
Same resultsa
Left ADx but persistent high BP and high ARR
8 11 mm L Contralateral LI bLI 4.6 (R)
sLI 14.2 (R)
2 bLI 14.4 (R)
sLI 9.2 (R)
Same results—R ADx shows 15-mm R mass not seen on CT; normal ARR and clinical cure
9 29 mm L Failed R cath bRSI 1.1
sRSI 1.1
2 bRSI 4.7
sRSI 52
Success but contralateral LI; MRA therapya
10 No lesion Lateralization with no adrenal mass bLI 34.7 (R)
sLI 27.6 (R)
43 bLI 114 (R)
sLI 60.8 (R)
Same results—Lateralized R
11 No lesion Failed L cath bLSI 1.0
sLSI 1.8
4 bLSI 1.6
sLSI 27.7
Success but no lateralization: MRA therapy
12 8 mm L Contralateral LI sLI 4.7 (R) 7 bLI 18.6 (R)
sLI 13.1 (R)
Same results
13 17 mm R Contralateral LI bLI 7.2 (L) 4 bLI 89.3 (R)
sLI 4.1 (R)
Same resultsa, left ADx but persistent high BP and ARR
14 No lesion Failed R cath bRSI 1.1
sRSI 1.1
2 bRSI 1.7
sRSI 105
Success but no lateralization: MRA therapy
15 No lesion Failed R cath bRSI 1.2
sRSI 0.9
2 bRSI 2.4
sRSI 31.8
Success but no lateralization: MRA therapy
16 16 mm R Contralateral LI bLI 2.7 (L)
sLI 6.6 (L)
3 bLI 2.0 (L)
sLI 1.5 (L)
Same resultsa,b
NP-59–positive mass, DHEAS suppressed. Surgery refused because of severe obesity
17 No lesion Lateralization with no mass bLI 3.9 (R)
sLI 1.35 (R)
20 bLI 2.1 (R)
sLI 1.94 (L)
Success but no lateralization: MRA therapy
18 10 mm L Contralateral LI bLI 7.4 (R)
sLI 6.6 (R)
3 bLI 11.0 (R)
sLI 7.0 (R)
Same results; R ADx. Pathology 0.9-cm adrenal mass, no hyperplasia. Normal ARR, BP improved
19 24 mm L Contralateral LI bLI 11.8 (R)
sLI 4.7 (R)
3 bLI 3.1 (R)
sLI 2.4 (R)
Same resultsa,b NP59-positive, ACTH suppressed. L ADx; postop ACTH now high but ARR still high with hypertension
20 18 mm L Discordant— nonlateralizing bLI 1.8 (L)
sLI 3.2 (R)
1 bLI 12.0 (R)
sLI 1.6 (R)
Same results
21 29 mm R Contralateral LI bLI 2.8 (L)
sLI 3.4 (L)
4 bLI 1.4 (L)
sLI 1.9 (L)
Same resultsa
22 No lesion Failed R cath bRSI 0.9
sRSI 1.0
3 bRSI 0.7
sRSI 1.6
Failed AVS
23 28 mm L Contralateral LI bLI 4.7 (R)
sLI 1.1 (R)
47 bLI 2.0 (R)
sLI 2.4 (L)
Same results (basal)a,b NP-59–positive mass, surgery L mass, normal ARR and BP improved

Abbreviations: ACTH, adrenocorticotropin; ADx, adrenalectomy; ARR, aldosterone-renin ratio; AVS, adrenal vein sampling; bLI, basal lateralization index; bLSI, basal left selectivity index; BP, blood pressure; bRSI, basal right selectivity index; cath, catheterization; CT, computed tomography; DHEAS, dehydroepiandrosterone sulfate; L, left; MRA, mineralocorticoid receptor antagonist; NP-59, 131I-iodocholesterol; R, right; sLI, stimulated lateralization index; sLSI, stimulated left selectivity index; sRSI, stimulated right selectivity index.

a Query cortisol cosecretion.

b See Supplementary material for more case details.